Sagert; Jason Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sagert; Jason Gary.The latest application filed is for "anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof".

Company Profile

23.21.36

Sagert; Jason Gary - San Mateo CA
Sagert; Jason Gary - Cambridge MA
SAGERT; Jason Gary - South San Francisco CA
- San Mateo CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20220306759 - Sagert; Jason Gary ; et al.	2022-09-29
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof App 20220298245 - West; James William ; et al.	2022-09-22
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Grant 11,267,896 - Sagert , et al. March 8, 2	2022-03-08
Epcam Antibodies, Activatable Antibodies, And Immunoconjugates, And Uses Thereof App 20210403594 - LIU; Yimao ; et al.	2021-12-30
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof App 20210355208 - MOORE; Stephen James ; et al.	2021-11-18
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof Grant 11,174,316 - West , et al. November 16, 2	2021-11-16
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof App 20210347886 - MOORE; Stephen James ; et al.	2021-11-11
Modified Antibody Compositions, Methods Of Making And Using Thereof App 20210284721 - Stagliano; Nancy Elizabeth ; et al.	2021-09-16
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof Grant 11,046,759 - Moore , et al. June 29, 2	2021-06-29
Bispecific Anti-cd3 Antibodies, Bispecific Activatable Anti-cd3 Antibodies, And Methods Of Using The Same App 20210047406 - IRVING; Bryan Allen ; et al.	2021-02-18
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof App 20210023243 - Lowman; Henry Bernard ; et al.	2021-01-28
Systems And Methods For Quantitative Pharmacological Modeling Of Activatable Antibody Species In Mammalian Subjects App 20210020264 - Stroh; Mark Anthony ; et al.	2021-01-21
Methods of treatment using activatable anti-EGFR antibodies Grant 10,875,913 - Stagliano , et al. December 29, 2	2020-12-29
Activatable Antibodies That Bind Interleukin-6 Receptor And Methods Of Use Thereof App 20200339694 - West; James William ; et al.	2020-10-29
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof App 20200291113 - WEST; James William ; et al.	2020-09-17
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof Grant 10,745,481 - West , et al. A	2020-08-18
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof App 20200231677 - West; James William ; et al.	2020-07-23
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof Grant 10,709,799 - Lowman , et al.	2020-07-14
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same Grant 10,669,337 - Irving , et al.	2020-06-02
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof Grant 10,669,339 - West , et al.	2020-06-02
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof Grant 10,611,845 - West , et al.	2020-04-07
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof Grant 10577420 -	2020-03-03
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof App 20190382493 - West; James William ; et al.	2019-12-19
Anti-jagged 1/jagged 2 Cross-reactive Antibodies, Activatable Anti-jagged Antibodies And Methods Of Use Thereof App 20190367589 - WEST; James William ; et al.	2019-12-05
Anti-itga3 Antibodies, Activatable Anti-itga3 Antibodies, And Methods Of Use Thereof App 20190309072 - SAGERT; Jason Gary ; et al.	2019-10-10
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof App 20190241652 - Moore; Stephen James ; et al.	2019-08-08
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20190202927 - Sagert; Jason Gary ; et al.	2019-07-04
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof Grant 10,336,824 - West , et al.	2019-07-02
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof Grant 10,301,380 - West , et al.	2019-05-28
Modified Antibody Compositions, Methods Of Making And Using Thereof App 20190119370 - Stagliano; Nancy Elizabeth ; et al.	2019-04-25
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof Grant 10,233,244 - Sagert , et al.	2019-03-19
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Grant 10,179,817 - Sagert , et al. Ja	2019-01-15
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof App 20180333507 - LOWMAN; Henry Bernard ; et al.	2018-11-22
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV Grant 10,118,961 - Stagliano , et al. November 6, 2	2018-11-06
Cd147 Antibodies, Activatable Cd147 Antibodies, And Methods Of Making And Use Thereof App 20180303952 - SAGERT; Jason Gary ; et al.	2018-10-25
Anti-EGFR activatable antibodies Grant 10,059,762 - Stagliano , et al. August 28, 2	2018-08-28
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof Grant 9,889,211 - Lowman , et al. February 13, 2	2018-02-13
Anti-jagged 1/jagged 2 Cross-reactive Antibodies, Activatable Anti-jagged Antibodies And Methods Of Use Thereof App 20170298125 - West; James William ; et al.	2017-10-19
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof App 20170196996 - Lowman; Henry Bernard ; et al.	2017-07-13
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof Grant 9,688,748 - West , et al. June 27, 2	2017-06-27
Modified Antibody Compositions, Methods Of Making And Using Thereof App 20170081397 - Stagliano; Nancy E. ; et al.	2017-03-23
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof Grant 9,545,442 - Lowman , et al. January 17, 2	2017-01-17
Activatable Antibodies That Bind Interleukin-6 Receptor And Methods Of Use Thereof App 20170002082 - West; James William ; et al.	2017-01-05
Anti-itga3 Antibodies, Activatable Anti-itga3 Antibodies, And Methods Of Use Thereof App 20160355592 - Sagert; Jason Gary ; et al.	2016-12-08
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof App 20160355587 - West; James William ; et al.	2016-12-08
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20160355599 - Sagert; Jason Gary ; et al.	2016-12-08
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof Grant 9,487,590 - West , et al. November 8, 2	2016-11-08
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof App 20160311903 - West; James William ; et al.	2016-10-27
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof App 20160289324 - Moore; Stephen James ; et al.	2016-10-06
Modified Antibody Compositions, Methods Of Making And Using Thereof App 20160228546 - Stagliano; Nancy Elizabeth ; et al.	2016-08-11
Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof App 20160200826 - West; James William ; et al.	2016-07-14
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof App 20160193332 - Lowman; Henry Bernard ; et al.	2016-07-07
Anti-cd3 Antibodies, Activatable Anti-cd3 Antibodies, Multispecific Anti-cd3 Antibodies, Multispecific Activatable Anti-cd3 Antibodies, And Methods Of Using The Same App 20160194399 - Irving; Bryan Allen ; et al.	2016-07-07
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof Grant 9,127,053 - West , et al. September 8, 2	2015-09-08
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof Grant 9,120,853 - Lowman , et al. September 1, 2	2015-09-01
Activatable Antibodies that Bind Interleukin-6 Receptor and Methods of Use Thereof App 20140363430 - West; James William ; et al.	2014-12-11
Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof App 20140010810 - West; James William ; et al.	2014-01-09
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof App 20130315906 - Lowman; Henry Bernard ; et al.	2013-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.